Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Active, not recruiting · NCT02905318 · Registry updated 2026-03-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2026-03-09 | NCT02905318 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Cancer Trials Group | 73 |
| Pfizer | 431 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Allan Blair Cancer Centre | Regina | Canada | 76 |
| CHUM-Centre Hospitalier de l'Universite de Montreal | Montreal | Canada | 20 |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton | Canada | 60 |
| London Regional Cancer Program | London | Canada | 15 |
| Odette Cancer Centre | Toronto | Canada | 20 |
| QEII Health Sciences Centre | Halifax | Canada | 11 |
| University Health Network | Toronto | Canada | 52 |